No worsening of spinal CSF leak symptoms : Given the research I recap below about intracranial hypertension and use of GLP-1RAs to lower intracranial pressure, I was very concerned that this class of medication could worsen my spinal CSF leak symptoms
doi:10.1001/jama.2020.22258 Okushi Y, Kusunose K, Nakai M, et al
How the FDA Drug Shortages Page Works The FDA Drug Shortages database has a search and browse interface at: Each shortage has a detail page with the drug name, reason for shortage, estimated resolution date, affected presentations, and related information
May your tirzepatide stay potent, your costs stay manageable, and your results stay consistent.
There are relatively few long-term adverse risks, but one is that the effects of GLP-1 receptor agonists include loss of both fat tissue and muscle
But now, the